Skip to content

Clinical trials

Scleroderma, Systemic trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Country / region: Belgium Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20111
20131
20153
20161
20181
20192
20201
20211
20223
20234
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting3
Not yet recruiting2
Recruiting2
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim4
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company2
Lakefront Biotherapeutics NV2
University Hospital, Ghent2
Actelion1
AstraZeneca1
Bayer1
Bristol-Myers Squibb1
Brugmann University Hospital1
Genentech, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic23
Arthritis, Rheumatoid3
Lung Diseases, Interstitial3
Lupus Erythematosus, Systemic3
Scleroderma, Diffuse3
Autoimmune Diseases2
Dry Eye Syndromes2
Myositis2
Sjogren's Syndrome2
Arthritis1

Trials

Showing 76 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.